Library

Home > Library > AYA analytic report on the top tech titans (MAMGA) May 2022

AYA analytic report on the top tech titans (MAMGA) May 2022

Author Peter Prince

Our fintech finbuzz analytic report shines fresh light on the fundamental prospects of U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon (aka M.A.M.G.A.). As of Spring-Summer 2022, this macro report focuses on the global supply chain issues and semiconductor microchip shortages in response to persistent demands of U.S. tech titans. The extant semiconductor microchip demand-supply imbalance remains severe for the U.S. tech and auto industries. It can take several years for the major semiconductor microchip manufacturers to build out new capacity during the current boom-bust business cycle. We expect adequate microchip supplies to meet tech and auto demands in 2023-2024 as the prevalent semiconductor capital investments bear fruit in due course. This macro trend has profound public policy implications for U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon.

Description:

Our fintech finbuzz analytic report shines fresh light on the fundamental prospects of U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon (aka M.A.M.G.A.). As of Spring-Summer 2022, this macro report focuses on the global supply chain issues and semiconductor microchip shortages in response to persistent demands of U.S. tech titans. The extant semiconductor microchip demand-supply imbalance remains severe for the U.S. tech and auto industries. It can take several years for the major semiconductor microchip manufacturers to build out new capacity during the current boom-bust business cycle. We expect adequate microchip supplies to meet tech and auto demands in 2023-2024 as the prevalent semiconductor capital investments bear fruit in due course. This macro trend has profound public policy implications for U.S. tech titans Meta, Apple, Microsoft, Google, and Amazon.

 

AYA fintech network platform provides proprietary alpha stock signals and personal finance tools for U.S. stock market investors and traders. Our quantitative analysis accords with the standard approach to discounting-cash-flows (DCF) and free-cash-flows (FCF) corporate valuation.

 

This analytic report cannot constitute any form of financial advice, analyst opinion, recommendation, or endorsement. We refrain from engaging in financial advisory services, and we seek to offer our analytic insights into the latest economic trends, stock market topics, investment memes, and other financial issues. Our proprietary alpha investment algorithmic system helps enrich our AYA fintech network platform as a new social community for stock market investors: https://ayafintech.network.

 

We share and circulate these informative posts and essays with hyperlinks through our blogs, podcasts, emails, social media channels, and patent specifications. Our goal is to help promote better financial literacy, inclusion, and freedom of the global general public. While we make a conscious effort to optimize our global reach, this optimization retains our current focus on the American stock market.

 

This analytic report shares new economic insights, investment memes, and stock portfolio strategies through both blog posts and patent specifications on our AYA fintech network platform. AYA fintech network platform is every investor's social toolkit for profitable investment management. We can help empower stock market investors through technology, education, and social integration.

 

Blog+More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

Yale economist Stephen Roach warns that America has much to lose from the current trade war with China for a few reasons.

Joseph Corr

2018-07-13 09:41:00 Friday ET

Yale economist Stephen Roach warns that America has much to lose from the current trade war with China for a few reasons.

Yale economist Stephen Roach warns that America has much to lose from the current trade war with China for a few reasons. First, America is highly dependent

+See More

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019.

James Campbell

2019-04-07 13:39:00 Sunday ET

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019.

CNBC news anchor Becky Quick interviews Warren Buffett in early-2019. Buffett explains the fact that book value fluctuations are a metric that has lost rele

+See More

U.S. regulatory agencies may consider broader economic issues in their antitrust probe into Amazon, Apple, Facebook, and Google.

Joseph Corr

2019-07-03 11:35:00 Wednesday ET

U.S. regulatory agencies may consider broader economic issues in their antitrust probe into Amazon, Apple, Facebook, and Google.

U.S. regulatory agencies may consider broader economic issues in their antitrust probe into tech titans such as Amazon, Apple, Facebook, and Google etc. Hou

+See More

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025.

James Campbell

2025-02-02 11:28:00 Sunday ET

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025.

Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2025. Our proprietary alpha investment model outperforms the ma

+See More

The Trump administration introduces new tariffs on $50 billion Chinese goods amid the persistent bilateral trade dispute.

Laura Hermes

2018-06-09 16:40:00 Saturday ET

The Trump administration introduces new tariffs on $50 billion Chinese goods amid the persistent bilateral trade dispute.

The Trump administration introduces new tariffs on $50 billion Chinese goods amid the persistent bilateral trade dispute. The tariffs effectively boost cost

+See More